Relief trade.
• Roche and Novartis are up 1+% on news that the Switzerland may avoid a Section 232 probe on pharmaceutical exports.
• Section 232 allows the President to impose tariffs on trade which is a threat to national security.
Find more articles and bullets on these widgets: